Professional Documents
Culture Documents
DEEPIKA SELVA
– 2015 update
AHA guidelines
BASIC LIFE SUPPORT– AHA
GUIDELINES
Chain of survival
CPR POSITION
High quality CPR
• Start compression within 10 sec of recognition of cardiac arrest.
• Position patient on hard surface in supine position
• Push hard Push fast:
Rate: 100-120/minute
Depth: 2-2.4” (5-6cm) 5 cm for children , 4 cm for infants.
• Allow complete recoil of chest (avoid leaning on the chest
between compressions)
• Minimize interruptions for ventilation (<10Sec)
• Give effective breath (2 breaths after 30 compressions, each
breath delivered over 1 second, each causing chest rise)
• Avoid excessive ventilation.
AIRWAY
HEAD TILT CHIN LIFT JAW THRUST
MOUTH – MOUTH BREATH
BARRIER DEVICES
AMBU BAG
E-C CLAMP TECHNIQUE
AUTOMATED EXTERNAL DEFIBRILLATOR
Electrode Placement
•4 pad positions
• anterolateral,
• anteroposterior,
• anterior-left infrascapular, and
• anterior-rightinfrascapular
• For adults, an electrode size of 8 to 12 cm is
reasonable
• Any of the 4 pad positions is reasonable for
defibrillation
ADULT PEDIATRIC
Sequence:
Choking
ADULT
Infants
summary
ADULT CHILDREN INFANTS
ADVANCED CARDIAC LIFE
SUPPORT– AHA GUIDELINES
REVERSIBLE CAUSES of CARDIAC
ARREST
H’s
T’s
• HYPOXIA • TAMPONADE
• HYPO/HYPERKALEMIA • THROMBOSIS,
• HYPOTHERMIA PULMONARY
• THROMBOSIS, CORONARY
Rhythm changes during cardiac arrest
Shokable rhythm Non-shockable rhythm
• Ventricular Tachycardia (VT) • PULSELESS ELECTRICAL
Monomorphic ACTIVITY (PEA)
Polymorphic • ASYSTOLE
• Ventricular Fibrillation (VF)
Coarse
Fine ( Close d/d for
asystole )
A
R
R
E PULSELESS
S ELECTRICAL
ACTIVITY
T
R ASYSTOLE
H
Y
T
NON-SHOCKABLE
H
MONOMORPHIC A
VT
R
R
POLYMORPHIC
E
VT
S
R
COARSE VF
Y
T
FINE VF
H
SHOCKABLE S
CARDIAC ARREST
NON SHOCKABLE RHYTHM ( PEA/
ASYSTOLE )
SHOCK
Monitoring During CPR
Physiologic parameters
• Monitoring of PETCO2 (35 to 40 mmHg)
• Coronary perfusion pressure (CPP)
(15mmHg)
• Central venous oxygen saturation (ScvO2)
Abrupt increase in any of these parameters
is a sensitive indicator of ROSC that can be
monitored without interrupting chest
compressions
Quantitative waveform capnography
• If Petco2 <10 mm Hg, attempt to improve
CPR quality Intra-arterial pressure
• If diastolic pressure <20 mm Hg, attempt to
improve CPR quality
• If ScvO2 is < 30%, consider trying to improve
the quality of CPR
Interventions Not Recommended for
Routine Use During Cardiac Arrest
• Atropine : Available evidence suggests that routine
use of atropine during PEA or asystole is unlikely to
have a therapeutic benefit
(30ml/kg)
To keep
MAP>65mm Hg
Targeted Temperature Management
• comatose adult patients with ROSC after cardiac arrest &
in- hospital cardiac arrest should have TTM for
“nonshockable”)
• Core Temperature Measurement If Comatose
• Induce therapeutic Hypothermia ( if no contraindications)
• Surface or endovascular cooling
• Cold IV fluid Bolus 30 mL/kg
• Selecting & maintaining a constant temperature of 32°C–
34°C×24 hours
• After 24 hours, Slow rewarming 0.25°C/hr
• to actively prevent fever in comatose patients after TTM
• routine prehospital cooling of patients after ROSC with
rapid infusion of cold intravenous fluids is NOT
recommended
• An EEG for the diagnosis of seizure should be
promptly performed and interpreted, and
then should be monitored frequently or
continuously in comatose patients after
ROSC.
• The same anticonvulsant regimens for the
treatment of status epilepticus caused by
other etiologies may be considered after
cardiac arrest
Prognostication After Cardiac
Arrest
• The earliest time to prognosticate a poor neurologic
outcome using clinical examination in patients not
treated with TTM is 72 hours after cardiac arrest, but
this time can be even longer after cardiac arrest if the
residual effect of sedation or paralysis is suspected to
confound the clinical examination
SINUS BRADYCARDIA
A
1ST DEGREE
V
2ND DEGREE
MOBIZ TYPE-1 B
(WENCKEBACH L
PHENOMENON) O
C
2ND DEGEREE K
MOBIZ TYPE-2
3RD DEGREE
COMPLETE
HEART BLOCK
CAUSES
• HYPOXIA
• HYPOTENSION
• ACIDOSIS
• ELECTROLYTE
IMBALANCE(HYPERKALEMIA)
• DRUGS ( β-BLOCKER, CCB, DIGOXIN)/
TOXINS
• INCREASED VAGAL TONE
• INTRINSIC SA/AV NODAL DISEASE
• CONGENITAL HEART/ CONDUCTION
DEFECT
ADULT TACHYCARDIA WITH A PULSE
ALGORHYTHM
TACHYCARDIA : RECOGNITION
SIGNS/SYMPTOMS ECG
• NONSPECIFIC & Differ acc • HR > FASTER for Age
to Age of the Child A.NARROW COMPLEX(≤0.09sec)
1. ST (MC) HR
• Palpitation
2. SVT( MC
• Light-headed ness/ tacchyarrythmia cardio-
syncope vascular compromise in
• Respiratory distress Infancy)
3. ATRIAL FLUTTER
• Shock
B. WIDE COMPLEX
• Altered mental status ( ≥0.09sec)
• Sudden collapse with 4. VT
rapid ,weak pulse 5. SVT with Aberrant
Conduction
SINUS
TACHYCARDI
A N
SUPRAVENTRIC A
ULAR
TACHYCARDIA R
R
ATRIAL
FLUTTER
O
VT W
MONOMORPHIC W
I
D
E
VT
POLYMORPHIC
ACUTE CORONARY SYNDROME
ALGORHYTHM
MANAGEMENT
ALGORHYTHM
Thrombolysis in Myocardial
Infarction
Thrombosis in Myocardial Infarction (TIMI) score is a seven item tool that helps
stratify patients with potential ACSs in the ED. Patients with a score of 0 to 2 have a 2%
to 9% 30-day risk of death, myocardial infarction, or revascularization. Patients with
higher scoreshave higher risks
DRUGS IN
STEMI
DRUGS IN
NSTEMI
Acute stroke - algorithm
REFERENCES